Condensed Consolidated Statements of Shareholders’ Deficit - USD ($) $ in Thousands	Total	Class A Common Stock	Class C Common Stock	Shareholders’ Deficit attributable to the Company	Common Stock Class A Common Stock	Common Stock Class C Common Stock	Treasury Stock	Paid-in Capital	Accumulated Deficit	NCI
Beginning balance (in shares) at Dec. 31, 2024					101,859,000	55,394,533
Beginning balance at Dec. 31, 2024	$ (1,008,034)			$ (1,009,262)	$ 10	$ 6	$ (12,825)	$ 0	$ (996,453)	$ 1,228
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	2,844			2,844				2,844
Cumulative preferred dividends	(147)			(147)				(147)
Accretion of preferred stock discount	(2)			(2)				(2)
Conversion of Series A preferred stock (Note 7) (in shares)					15,358,229
Conversion of Series A preferred stock (Note 7)	176,554			176,554	$ 2			176,552
Repurchase of Class A common stock	(20,700)						(20,700)
Class A common stock issued for stock options exercised (in shares)					18,790
Class A common stock issued for stock options exercised	(69)			(69)				(69)
Class A common stock issued for vested RSUs and PSUs (in shares)					500,580
Class A common stock issued related to RSU and RSS awards	(3,436)			(3,436)				(3,436)
Class A common stock issued for Class C canceled (in shares)					1,592,729	(1,592,729)
Issuance of stock (in shares)						7,500,000
Issuance of stock	167,525			167,525				167,525
Subsequent remeasurement of redeemable noncontrolling interests	561,176			561,176				(343,267)	904,443
Net income attributable to noncontrolling interest	462									462
Net loss attributable to the Company	(11,396)			(11,396)					(11,396)
Ending balance (in shares) at Mar. 31, 2025					119,329,328	61,301,804
Ending balance at Mar. 31, 2025	(135,223)			(136,913)	$ 12	$ 6	(33,525)	0	(103,406)	1,690
Beginning balance (in shares) at Dec. 31, 2025		121,281,880	58,628,185		123,472,960	58,628,185
Beginning balance at Dec. 31, 2025	(754,447)			(754,964)	$ 12	$ 6	(33,525)	0	(721,457)	517
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	8,842			8,842				8,842
Cumulative preferred dividends	(162)			(162)				(162)
Accretion of preferred stock discount	(1)			(1)				(1)
Acquisition of KinetX and related adjustments (Note 3 and 9) (in shares)					22,991,028
Acquisition of Lanteris and related adjustments (Notes 3)	$ 403,689			403,689	$ 2			403,687
Class A common stock issued related to contingency consideration release (Notes 3 and 16) (in shares)					13,336
Class A common stock issued for stock options exercised (in shares)	0
Class A common stock issued for vested RSUs and PSUs (in shares)					2,325,590
Class A common stock issued related to RSU and RSS awards					$ 1			(1)
Class A common stock issued for Class C canceled (in shares)					1,633,818	(1,633,818)
Issuance of stock (in shares)					11,574,069
Issuance of stock	$ 167,450			167,450	$ 1			167,449
Subsequent remeasurement of redeemable noncontrolling interests	(121,764)			(121,764)				(579,814)	458,050
Net income attributable to noncontrolling interest	343									343
Net loss attributable to the Company	(37,387)			(37,387)					(37,387)
Ending balance (in shares) at Mar. 31, 2026		159,819,721	56,994,367		162,010,801	56,994,367
Ending balance at Mar. 31, 2026	$ (333,437)			$ (334,297)	$ 16	$ 6	$ (33,525)	$ 0	$ (300,794)	$ 860